Transcode Therapeutics, Inc.
RNAZDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Transcode Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in Transcode Therapeutics, Inc.'s (RNAZ) pipeline across Phase 2. Its lead program is TTX-MC138 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Transcode Therapeutics, Inc.'s next FDA catalyst?→
Transcode Therapeutics, Inc.'s (RNAZ) next tracked catalyst is a Earnings expected November 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track RNAZ biotech catalysts?→
Add RNAZ to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Transcode Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.